Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | GMNN | O75496 | 1/20 | 0.42 |
| ▸ | PPM1B | O75688 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.42 |
| ▸ | TFPI2 | P48307 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | PPP5C | P53041 | 1/20 | 0.42 |
| ▸ | PPP1CA | P62136 | 1/20 | 0.42 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | THPO | P40225 | 1/20 | 0.42 |
| ▸ | STS | P08842 | 3/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | FNTA | P49354 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL598374 | 1.00 | KDM4E (0.42) | KDM4EGMNNPPM1BLMNAPPP1CC | |
| SCHEMBL45910 | 1.00 | KDM4E (0.42) | KDM4EGMNNPPM1BLMNAPPP1CC | |
| SCHEMBL15324 | 1.00 | KDM4E (0.42) | KDM4EGMNNPPM1BLMNAPPP1CC | |
| SCHEMBL6237465 | 1.00 | KDM4E (0.42) | KDM4EGMNNPPM1BLMNAPPP1CC | |
| SCHEMBL38660910 | 1.00 | KDM4E (0.42) | KDM4EGMNNPPM1BLMNAPPP1CC | |
| SCHEMBL45891 | 1.00 | KDM4E (0.42) | KDM4EGMNNPPM1BLMNAPPP1CC | |
| SCHEMBL24453322 | 0.97 | KDM4E (0.40) | KDM4EGMNNPPM1BLMNAPPP1CC | |
| SCHEMBL20963086 | 0.97 | KDM4E (0.40) | KDM4EGMNNPPM1BLMNAPPP1CC | |
| SCHEMBL20963058 | 0.97 | KDM4E (0.40) | KDM4EGMNNPPM1BLMNAPPP1CC | |
| SCHEMBL16020384 | 0.97 | STS (0.40) | KDM4EGMNNPPM1BLMNAPPP1CC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1215 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025242877-A1 | THERMAL ENERGY STORAGE DEVICE, COMPOSITION AND METHOD THEREFOR | FUNDACIÓN CENTRO DE INVESTIGACIÓN COOPERATIVA DE ENERGÍAS ALTERNATIVAS CIC ENERGIGUNE FUNDAZIOA (ES) | 2025-11-27 | — | — | WO | claimed |
| EP-4594382-A1 | OPTIONALLY SILYLATED IONIC POLYURETHANE(S) | Bostik SA (FR) | 2025-08-06 | — | — | EP | claimed |
| US-20250145576-A1 | CATHEPSIN K INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF | SHANDONG NEW TIME PHARMACEUTICAL CO., LTD. (CN) | 2025-05-08 | — | — | US | claimed |
| CN-119613892-A | Wave-absorbing PVC (polyvinyl chloride) structural foam and preparation method thereof | 洛阳思维诺新材料科技有限公司 | 2025-03-14 | — | — | CN | claimed |
| CN-115772674-B | Electrochemical method for preparing cis-hexahydrophthalic anhydride from phthalic anhydride in one step | 大连理工大学 | 2025-01-17 | — | — | CN | claimed |
| EP-4467544-A1 | CATHEPSIN K INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Shandong New Time Pharmaceutical Co., Ltd. (CN) | 2024-11-27 | — | — | EP | claimed |
| CN-118742549-A | Cathepsin K inhibitor, preparation method and application thereof | 山东新时代药业有限公司 | 2024-10-01 | — | — | CN | claimed |
| CN-118203671-A | Nanometer medicinal composition based on charge assembly and having responsiveness, and preparation method and application thereof | 锐康九域(厦门)医药科技有限公司 | 2024-06-18 | — | — | CN | claimed |
| CN-118027579-A | Hydrostatic pressure-resistant polyvinyl chloride structural foam and preparation method thereof | 洛阳科博思新材料科技有限公司 | 2024-05-14 | — | — | CN | claimed |
| CN-115746276-B | High-performance polyester resin and preparation method and application thereof | 安徽美佳新材料股份有限公司 | 2024-04-30 | — | — | CN | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
| EP-0674233-A2 | Recording sheets | XEROX CORPORATION (US) | 1995-09-27 | — | — | EP | claimed |
| US-5374676-A | For lightweight moldings having impact strength and shrinkage inhibition | ASHLAND OIL, INC. (US) | 1994-12-20 | — | — | US | claimed |
| EP-0400746-B1 | Cross-linkable compositions based on polyphenylene ethers and unsaturated monomers copolymerizable radically | ENICHEM SPA (IT) | 1994-06-22 | — | — | EP | claimed |
| US-4465809-A | BY REACTING WITH EPOXY COMPOUND THEN CYCLIC ANHYDRIDE, HYDROLYZING; SHEET MOLDING COMPOUNDS | PHILLIPS PETROLEUM COMPANY (US) | 1984-08-14 | — | — | US | claimed |
| US-4318344-A | Spinning tubular projectile combustible sabot | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1982-03-09 | — | — | US | claimed |
| US-3998763-A | STORAGE STABLE, A SALT OF BIS(FLUOROALKYLSULFONYL) METHANE OR FLUOROALKYLSULFONIC ACID AS LATENT CATALYST, PHOSPHORUS PENTOXIDE AND A BASE | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1976-12-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250145576-A1 | CATHEPSIN K INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF | CTSF, CTSK, CTSZ | KDM4E 2060/4885GMNN 1396/4885PPM1B 2311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.